FDA’s regulatory actions against sports supplement manufacturer [USPlabs LLC] prompted Sen. Dick Durbin to inquire about a potentially dangerous ingredient, aegeline, used in the firm’s products.
In an Oct. 29 letter to the Dallas-based firm, the Illinois Democrat expressed “concern regarding mounting evidence” that USPlabs’ products...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?